A
Alnylam
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
About Alnylam
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
Investors & Backers
Alnylam has received investment from 3 venture capital firms.
Company Details
- Sector
- Biotech
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2002
- Status
- Active